“Venetoclax-based lower-intensity regimens for acute myeloid leukemia: Clinical pearls for a new standard of care”, Can Hematol Today, vol. 2, no. 1, pp. 28–33, Mar. 2023, doi: 10.58931/cht.2023.2125.